HOME > News

News

2014

Dec. 11 Jitsubo Co., Ltd. agrees to be acquired by Sosei Group Corporation (TSE Mothers: 4565) (Release)
Nov. 14 Takuro Wakabayashi speaks at Education Academy of Computational Life Sciences, Tokyo Institute of Technology.
Nov. 8 ASON Technology Co., Ltd. featured by OLED-Info.
Oct. 1 TMS Co., Ltd. enters into PhaseI clinical trial of its TMS-007.
Mar. 19 TMS Co., Ltd. received Grand Prix at prestigeous Bio Business Award Japan, selected by a panel of Pharmaceutical companies. (Release, in Japanese)
Feb. 26  Cinemacraft announces investment from Samsung Ventures and Tyra Banks. (Article

2013

Oct. 1 Prof. Robert Kneller (J.D., Ph.D, M.P.H.) becomes an advisor to ASTEC.
Sep. 17 Cinemacradt raises $1.5m from NTT DoCoMo, Turner Broadcasting's Media Camp, and 500 Startups.
Jun. 20 Cinemacraft becomes one of five companies admitted by an accelerator program "Media Camp" by Turner/Warner Bros. (Article)
Jun. 18 TechnoStar and MSC Software Japan start selling "MSC Nastran Desktop for TSV" as of July 2013.
Jun. 11 Rennaissance Energy Research discloses co-development of CO2 separation and sequestration equipment with JAXA.
May. 14 ASTEC participates in START program (Program for Creating STart-ups from Advanced Research and Technology) by MEXT and JST, as a co-promoter with Tsukuba Technology Seed.
May. 13 Skylight Biotech announces it signed share exchange agreement with Immuno-Biological Laboratories Co., Ltd. Details are here.
Apr. 30 BioMedCore receives a NEDO grant for its "Development of DDS lipsome for ophtalmic diseases" project.
   

2012

Dec. 11 UMN Pharma went public (TSE Mothers 4585).
Nov. 22 Epiphotonics, a leader in ultra high speed and low electricity consumption optical switching device, completed 200m JPY financing round.
Nov. 15 Cinemacrft's product "Videogram" won KDDI prize at TechCrunch Tokyo. Details are here.
Nov. 6 UMN Pharma's IPO to TSE Mothers is approved.
Oct. 16 Renaissance Energy Research (RER) agreed to form a JV company with Sumitomo Chemical and Sumitomo Corporation, to commercialize RER's CO2 separation technology. Details are here.
Oct. 9 Memorandum of Understandings for the Co-development and Exclusive Commercialization Rights of UMN Pharma’s Recombinant Influenza HA Vaccine in South Korea with ILDONG PHARMACEUTICAL.
Sep. 30  ASON Technology, a leader in high-efficiency and high-quality OLED lighting panel, competed 495m JPY financing round.
Jul. 31 Takuro Wakabayashi is appointed as a member of Judge Committee at "Kanagawa Business Audition 2012", one of Japan's oldest business plan competitions.
Mar. 30 ASON Technology is selected as a grantee from the Ministry of Enviroment and eligible to receive up to 500 million JPY grant.
Feb. 22 Advanced Photonics released Active Optical Cable for Infiniband DDR/QDR, tested and accepted by IBTA (Infiniband Trade Association). Details of the product is here.
Feb. 14 UMN Pharma entered into a licensing agreement with Timo Vesikari, M.D. and Vesna Blazevic, Ph.D. that provides UMN Pharma with exclusive worldwide rights to develop and commercialize a novel norovirus VLP + rotavirus VP6 non-live injectable vaccine. (Release)
Feb. 7 UNIGEN, UMN Pharma's subsidiary, is selected in METI's "Subsidy for Domestic Location Promotion Projects", eligible for significant grant. (Release)
Jan. 16 Cinemacraft received additional funding from Dave McClure's 500 Startups. (TechCrunch)
Jan. 10 Takuro Wakabayashi participated in a panel discussion at a symposium "Building International University-Business Links" at British Embassy.
   

 2011

Dec. 21 UMN Pharma announced favorable immunogenicity and tolerability was was observed in Phase I/II clinical trial for seasonal flu vaccine UMN-0502 (ASP7374). (Release)
Dec. 19 EpiPhotonics announced successful development of lower-loss PLZT waveguides for nano-second optical switching. (Release)
Dec. 1 Takuro Wakabayashi appeared on Nikkei Business Daily. "TiE Japan empowering globalization of Japanese startups."
Oct. 24 TMS selected in "A-STEP" program by JST (Japan Science and Technology Agency), granted pre-clinical and Phase I clinical trial expenses of its novel molecule for ischemic stroke treatment.
Sep. 27 Advanced Photonics appeared on Nikkei Business Daily. "Server electricity consumption reduced by 80% using optical date transfer."
Aug. 16 BioMedCore selected in "A-STEP" program by JST.

Advanced Science and Technology Enterprise Corporation

先端科学技術エンタープライズ株式会社